Genmab is a biotechnology company specializing in the creation and development of differentiated antibody therapeutics to fight against cancer and other serious diseases.Genmab’s proprietary pipeline includes bispecific T-cell engagers, next generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. Come visit their location near Princeton where they are hiring postdocs and scientists to learn more about this growing company.
